HYPERFINE INC

HYPR is the ticker symbol for Hyperfine, Inc., a medical device company. Its stock trades on the Nasdaq under the symbol HYPR. The company develops portable magnetic resonance imaging (MRI) technology, including the Swoop system, designed to provide accessible imaging at the point of care. As with any stock, HYPR represents an ownership interest in the underlying business.

The current price of HYPR stock changes continuously during market hours as shares are bought and sold. For the latest price, please refer to the live quote displayed on this page. That quote reflects the most recent trade and may include the day's change, volume, and other real-time data.

Valuation for HYPR can be assessed using several approaches. Common metrics include price-to-sales, price-to-book, and enterprise value relative to revenue. Because HYPR is a smaller, growth-oriented medical device company, it may not have a meaningful price-to-earnings ratio if it is not yet consistently profitable. Comparing these metrics to peers and considering cash flows can provide context.

HYPR stock can be traded during regular U.S. market hours, typically from 9:30 a.m. to 4:00 p.m. Eastern Time, Monday through Friday, excluding market holidays. Some brokers also offer pre-market and after-hours trading sessions, though liquidity and spreads may differ from regular hours. Check with your brokerage for specific session availability.

Key metrics for HYPR include revenue growth, gross margin, operating expenses, cash burn, and cash position. Investors may also review the number of units sold, recurring revenue from service contracts, and progress toward profitability. These figures are reported in quarterly and annual filings, which provide the most reliable basis for analysis.

Risks for HYPR include regulatory hurdles, competition from larger medical imaging companies, adoption challenges for new technology, and the need for ongoing capital. As a smaller company, it may have limited financial resources and its stock price can be volatile. These factors, among others, can affect performance and should be considered alongside the company's disclosures.